Breckenridge Pharmaceutical Overview

  • Year Founded
  • 1983

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 76

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

  • Investments
  • 2

Breckenridge Pharmaceutical General Information

Description

Manufacturer of generic pharmaceuticals intended to serve the United States healthcare market. The company's products include tablets, capsules, soft gel capsules, liquids, suspensions, ophthalmic powders, nasal sprays and powders.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 200 Connell Drive
  • NJ 07922
  • United States
+1 (860)
Primary Industry
Pharmaceuticals
Other Industries
Other Consumer Non-Durables
Parent Company
Vertical(s)
Corporate Office
  • 200 Connell Drive
  • NJ 07922
  • United States
+1 (860)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Breckenridge Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Breckenridge Pharmaceutical‘s full profile, request access.

Request a free trial

Breckenridge Pharmaceutical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of generic pharmaceuticals intended to serve the United States healthcare market. The company's products in
Pharmaceuticals
NJ
76 As of 2025

Sarasota, FL
 

Hauppauge, NY
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Breckenridge Pharmaceutical Competitors (6)

One of Breckenridge Pharmaceutical’s 6 competitors is Wellspring Pharmaceutical, a Private Equity-Backed company based in Sarasota, FL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Wellspring Pharmaceutical Private Equity-Backed Sarasota, FL
LNK International Corporation Hauppauge, NY
Tris Pharma Private Debt Financed Monmouth Junction, NJ
Guardian Drug Company Corporation South Brunswick Township, NJ
Teligent Corporation Buena, NJ
To view Breckenridge Pharmaceutical’s complete competitors history, request access »

Breckenridge Pharmaceutical Patents

Breckenridge Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11013729-B2 Oral pharmaceutical compositions of dabigatran etexilate Active 21-Feb-2012
US-11752142-B2 Oral pharmaceutical compositions of dabigatran etexilate Active 21-Feb-2012
US-20150030680-A1 Oral pharmaceutical compositions of dabigatran etexilate Active 21-Feb-2012
US-20210244719-A1 Oral pharmaceutical compositions of dabigatran etexilate Active 21-Feb-2012
US-20240139168-A1 Oral pharmaceutical compositions of dabigatran etexilate Inactive 21-Feb-2012 A61K31/4439
To view Breckenridge Pharmaceutical’s complete patent history, request access »

Breckenridge Pharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Breckenridge Pharmaceutical Investments & Acquisitions (2)

Breckenridge Pharmaceutical’s most recent deal was a Corporate Asset Purchase with Nostrum Laboratories (Five Abbreviated New Drug Applications). The deal was made on 03-Oct-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Nostrum Laboratories (Five Abbreviated New Drug Applications) 03-Oct-2017 Corporate Asset Purchase Buildings and Property
Cypress Pharmaceuticals (Certain Assets) 11-Sep-2013 Merger/Acquisition Drug Discovery
To view Breckenridge Pharmaceutical’s complete investments and acquisitions history, request access »

Breckenridge Pharmaceutical FAQs

  • When was Breckenridge Pharmaceutical founded?

    Breckenridge Pharmaceutical was founded in 1983.

  • Where is Breckenridge Pharmaceutical headquartered?

    Breckenridge Pharmaceutical is headquartered in NJ.

  • What is the size of Breckenridge Pharmaceutical?

    Breckenridge Pharmaceutical has 76 total employees.

  • What industry is Breckenridge Pharmaceutical in?

    Breckenridge Pharmaceutical’s primary industry is Pharmaceuticals.

  • Is Breckenridge Pharmaceutical a private or public company?

    Breckenridge Pharmaceutical is a Private company.

  • What is Breckenridge Pharmaceutical’s current revenue?

    The current revenue for Breckenridge Pharmaceutical is .

  • Who are Breckenridge Pharmaceutical’s competitors?

    Wellspring Pharmaceutical, LNK International, Tris Pharma, Guardian Drug Company, and Teligent are some of the 6 competitors of Breckenridge Pharmaceutical.

  • When was Breckenridge Pharmaceutical acquired?

    Breckenridge Pharmaceutical was acquired on 04-Dec-2009.

  • Who acquired Breckenridge Pharmaceutical?

    Breckenridge Pharmaceutical was acquired by Pensa Investments.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process